This inventor holds 6 USPTO granted patents and 1 published patent application and 3 EPO patents. Top assignees: Valneva Austria Gmbh, Valneva USA, Inc., Intercell USA, Inc.. Active years: 2017-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
6 out of 46 
5 out of 5 
1 out of 1 Years Active: 2017-2025
Title: Larry R Ellingsworth: Innovator in Toxin Neutralization
Introduction
Larry R Ellingsworth is a notable inventor based in Rockville, MD (US). He holds a total of 6 patents that contribute significantly to the field of toxin neutralization. His work focuses on isolated polypeptides derived from toxin A and toxin B proteins, which have important applications in medical science.
Latest Patents
Among his latest patents is the invention of isolated polypeptides of the toxin A and toxin B proteins. This invention provides C-TAB.G5 and C-TAB.G5.1 isolated polypeptides that comprise the receptor binding domains of toxin A and toxin B, as detailed in the amino acid sequences of SEQ ID NO: 2 and SEQ ID NO: 4. These isolated polypeptides are designed to neutralize the toxic effects of toxin A and/or toxin B, showcasing the potential for therapeutic applications.
Career Highlights
Throughout his career, Larry has worked with prominent companies such as Valneva Austria GmbH and Valneva USA, Inc. His contributions to these organizations have been instrumental in advancing research and development in the field of toxin neutralization.
Collaborations
Larry has collaborated with notable colleagues, including David Flyer and Jing-Hui Tian. These partnerships have enhanced his research efforts and contributed to the success of his inventions.
Conclusion
Larry R Ellingsworth is a distinguished inventor whose work in toxin neutralization has made a significant impact in the field. His innovative patents and collaborations reflect his commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile